Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
(9th July, 2014); The meeting of the apex committee held on 17-06-2014 under the chairmanship secretary of health and family welfare for supervising clinical trials (CTs) on new chemical entities in the light of directions of the honorable supreme court of India dated 03.01.2013
(Business Wire India; 9th July, 2014); HealthCare Global Enterprises Ltd, The Specialist in Cancer Care, organized a press conference on the topic cancer patients suffer due to non availability of drugs.
(8th July, 2014); Dr Harsh Vardhan, Union Health Minister, has formed a core group to plan a detailed plan of action to eradicate the dreaded vector-borne disease Kala Azar by 2015.
(8th July, 2014); Health Ministry of India finalized that if any drug banned by two or more countries and it is still being marketed in India, they may possibly remove the drug from the Indian market after proper examination or appropriate action will be taken.
(3rd July, 2014); Four new vaccines are introduced as part of India’s Universal Immunization Programme (UIP), announced by Shri Narendra Modi, Prime Minister of India. Vaccines against rotavirus, rubella and polio (injectable) will collectively expedite India’s progress on meeting the Millennium Development Goal 4 targets to reduce child mortality by two-thirds by the year 2015 and meet global polio eradication targets. In addition, an adult vaccine against Japanese encephalitis will be introduced in districts with high levels of the disease.
(Business Wire India; 20th June, 2014); Boehringer Ingelheim today announces a new study of Pradaxa® (dabigatran etexilate) in patients with atrial fibrillation (AF). The RE-CIRCUIT™ study will investigate the safety and efficacy of uninterrupted anticoagulant treatment with Pradaxa® in patients with AF who undergo ablation. Results of the study are expected in 2016.
[adsense:336x280:8701650588]
(Business Wire India; 19th June, 2014); Wincere Inc., a visionary full service contract research organization and life sciences focused consulting company today organized a panel discussion in association with International CMEs Oncology on “Precision Medicine – Trends in Oncology”, promising to revolutionize cancer research.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
